Safety and efficacy of Naga Bhasma in diabetes mellitus
Phase 1
- Conditions
- Health Condition 1: null- Madhumeha (Diabetes mellitus type 2)
- Registration Number
- CTRI/2017/02/007765
- Lead Sponsor
- Institute for Post Graduate Teaching and Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Patients having classical symptomatology (Prabhuta Mutrata, Avila Mutrata, Kshudhadhikya, Trishnadhikya, Kara-Pada-tala Daha, Kara-Pada Suptata etc.) of Madhumeha
Symptoms of Diabetes (Polyuria, Polydipsia, Polyphagia and Weight loss.)
Both the sexes having Age between 30 years to 60 years.
Patients having Blood sugar Fasting more than 126 and equal to or less than 200 mg/dl or PPBS more than 200 mg/dl
Exclusion Criteria
Age below 30 and above 60 years.
Patients of Diabetes Mellitus receiving Insulin.
Malignant and accelerated Hypertension.
Patients having chronic complications of Diabetes Mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that the trial drugs will exert a <br/ ><br>significant action over FBS and PPBS and other associated symptomsTimepoint: 18 months
- Secondary Outcome Measures
Name Time Method By maintaining the healthy level of blood sugar, the <br/ ><br>drug will control conditions associated with <br/ ><br>diabetes like various cardiovascular <br/ ><br>diseases, obesity and improve quality of lifeetc.Timepoint: 60 days